Our BioTalent Social community came together for an informative discussion on ‘The Next Generation of Cell & Gene Therapies,’ hosted by our very own James Hume. The discussion touched on a multitude of topical themes and insights, including:
- The role of tech-transfer offices in turning early-stage interventions into products
- Current challenges and opportunities for CGT start-ups in Europe
- The complexities of clinical trials, and how we can make this smoother
- PHDs: the importance of scientific and entrepreneurial learning
- Viral vs. non-viral vectors
- Mindset in CGT: the importance of resilience, perseverance and ambiguity tolerance
Thank you to our wonderful panel members Stephen Sullivan, Kerstin Papenfuss and John Counsell for their sharp and focussed insights.
